M6G, A New Morphine Derivative For Post-Operative Pain Relief

Results from CeNes Pharmaceuticals' M6G015, its initial phase III study. As the graph shows, M6G provided effective analgesia to patients in the post-operative period following knee replacement surgery under spinal nerve block.


«Back	\|	Next»

Return to Profile